ℹ️
🇬🇧
Search
Search for publications relevant for "přežití bez známek progrese"
přežití bez známek progrese
Publication
Class
Person
Publication
Programmes
Export current view
publication
Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-resistant Prostate Cancer after Chemotherapy
2016 |
First Faculty of Medicine
publication
Axtinib in treatment metastatic renal cell carcinoma
2016 |
First Faculty of Medicine
publication
The authors' own experience with axitinib in treating metastatic renal cell carcinoma
2018 |
First Faculty of Medicine
publication
Trifluridin/tipiracil in treatment of refractory metastatic colorectal cancer - early clinical experience
2017 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Dabrafenib in the treatment of metastatic melanoma
2014 |
Publication without faculty affiliation
publication
Cabozantinib treatment - case report
2020 |
First Faculty of Medicine
publication
Regorafenib - role of the drug in the current real-life oncological practice
2018 |
Publication without faculty affiliation
publication
Avelumab plus axitinib combination in treating metastatic renal cell carcinoma
2022 |
First Faculty of Medicine
publication
Trabectedin registry
2011 |
Publication without faculty affiliation
publication
Current status of nephrectomy in the treatment of metastatic renal cell carcinoma
2023 |
Faculty of Medicine in Hradec Králové
publication
Cabozantinib in the treatment of metastatic renal cell carcinoma - final data analysis from four oncology centers in the Czech Republic
2021 |
First Faculty of Medicine
publication
Enzalutamide and abiraterone in the treatment of patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy
2023 |
First Faculty of Medicine
publication
Non-Hodgkin's lymphoma subtype distribution and survival in Czech Republic
2007 |
Publication without faculty affiliation